Search Result
1 |
Synergistic effect of Allium sativum and gliclazide on
pharmacokinetic parameters in rabbit models
Abstract |
Fulltext
|
2 |
Validation of HPLC-UV for simultaneous analysis of moxifloxacin and ciprofloxacin in peritoneal fluid
Abstract |
Fulltext
|
3 |
Evaluation of azithromycin–resin suspension designed for
taste-masking and sustained-release
Abstract |
Fulltext
|
4 |
Potential role of CI-679 against artemisinin-resistant Plasmodium falciparum
Abstract |
Fulltext
|
5 |
Promising reduction of de novo resistance to endocrine therapies in breast cancer by small molecules from natural origin: A structural approach
Abstract |
Fulltext
|
6 |
Cytotoxic effect of Eudragit L-100 nanoparticle-based cisplatin on lung cancer
Abstract |
Fulltext
|
7 |
Development, optimization, and in vitro/in vivo evaluation of ranitidine hydrochloride- resinate sustained-release suspension
Abstract |
Fulltext
|
8 |
Co-delivery of combretastatin A4 and docetaxel with pegylated nanostructured lipid carriers in tumor cells
Abstract |
Fulltext
|
9 |
A new steroidal derivative from the skin of Indian Toad (Bufo melanostictus) as a hypolipidemic and CYP 3A inhibitor
Abstract |
Fulltext
|
10 |
A new sensitive HPLC/UV method for simultaneous determination of paclitaxel, sorafenib and omeprazole in standard solutions and spiked plasma: Application to in-vitro and in-vivo evaluation of paclitaxel polymeric nanoformulations
Abstract |
Fulltext
|
11 |
Studies of the pharmacokinetics of morroniside and loganin in rat after oral administration of raw and wine-processed Corni fructus by UPLC-QqQ-MS/MS
Abstract |
Fulltext
|
12 |
Prediction of steady-state plasma concentrations of olanzapine in Chinese Han in patients based on a retrospective population pharmacokinetic model
Abstract |
Fulltext
|
13 |
Computational design of phosphoinositide 3-kinase gamma (PI3Kg) inhibitors as a newer therapy for rheumatoid arthritis
Abstract |
Fulltext
|
14 |
Studies on the pharmacokinetics of piperacillin/ tazobactam in renal replacement therapy in patients with chronic renal failure
Abstract |
Fulltext
|
15 |
Spectrodensitometric and ultra-performance liquid chromatographic quantification of dapagliflozin and saxagliptin in their dosage form and human plasma
Abstract |
Fulltext
|
16 |
Solid-phase extraction and validated spectrofluorimetric quantification of pamidronate in human plasma
Abstract |
Fulltext
|
17 |
Ultra-performance liquid chromatography–tandem mass spectrometric determination of ramipril in human plasma
Abstract |
Fulltext
|
18 |
Solid phase extraction and LC-MS/MS quantification of ibandronate in human plasma
Abstract |
Fulltext
|
19 |
Computational and pharmacological evaluation of stevioside derivatives for antinociceptive and anti-inflammatory potential
Abstract |
Fulltext
|
20 |
Disposition kinetics of ceftriaxone and determination of its therapeutic dose in dogs
Abstract |
Fulltext
|
21 |
Formulation, characterization and wound-healing potential of emulgel and in-situ gel containing root extract of Saussurea lappa Clarke (Asteraceae)
Abstract |
Fulltext
|
22 |
A reliable chromatographic method for the simultaneous determination of ciprofloxacin and moxifloxacin in human serum
Abstract |
Fulltext
|
23 |
Effect of Wuling powder on the pharmacokinetics of valproic acid in epileptic rats
Abstract |
Fulltext
|
24 |
Comparative pharmacokinetic study of five flavonoids in normal rats and rats with gastric ulcer following oral administration of Mongolian medicine, Shudage - 4 by UPLC-ESI-MS/MS
Abstract |
Fulltext
|
25 |
Biodistribution and pharmacokinetic studies on topically-delivered technetium-99m-labeled 5-FU nanogel formulation for management of pre-cancerous skin lesions
Abstract |
Fulltext
|
26 |
Pharmacokinetic, acute toxicity, and pharmacodynamic studies of semen strychni total alkaloid microcapsules
Abstract |
Fulltext
|
27 |
In silico model and design of novel 5α-reductase inhibitors for treatment of benign prostatic hyperplasia
Abstract |
Fulltext
|
28 |
A UHPLC-Q-Exactive-Orbitrap-MS method for simultaneous determination of three flavonoids from Parasitic loranthus and their pharmacokinetics in rat plasma
Abstract |
Fulltext
|
29 |
Simple and sensitive chromatographic method development for in-vitro and in-vivo analysis of doxorubicin-loaded poly lactic-co-glycolic acid nanoparticles
Abstract |
Fulltext
|
30 |
Penetration and pharmacokinetics of ferulic acid after dermal administration
Abstract |
Fulltext
|
31 |
Synthesis and cytotoxicity studies on new pyrazole-containing oxime ester derivatives
Abstract |
Fulltext
|
32 |
Development and validation of a chromatographic method for quantification of rasagiline in human plasma
Abstract |
Fulltext
|
33 |
Population pharmacokinetics of vancomycin in Jordanian patients
Abstract |
Fulltext
|
34 |
Pharmacokinetics of enantiomers of oxiracetam in rats
Abstract |
Fulltext
|
35 |
In silico design of small molecules targeting cathepsin-k for the treatment of osteoarthritis
Abstract |
Fulltext
|
36 |
Evaluation of pharmacokinetics and toxicology of biosimilar APZ001 antibody in Macaca cynomolgus
Abstract |
Fulltext
|
37 |
Fatal France clinical trial and the lessons learned: Application of in silico approaches to investigate the disposition of B1A10-2474 and possible safety concerns
Abstract |
Fulltext
|
38 |
Solid phase extraction method for determination of mitragynine in urine and its application to mitragynine excretion study in rats receiving caffeine
Abstract |
Fulltext
|
39 |
In vitro pharmacokinetics of sirolimus-coated stent for tracheal stenosis
Abstract |
Fulltext
|
40 |
Pharmacokinetics and tissue distribution of N-3-methoxybenzyl-palmitamide in rat: A macamide derived from Lepidium meyenii
Abstract |
Fulltext
|
41 |
Pharmacokinetics of a telmisartan, amlodipine and hydrochlorothiazide fixed-dose combination: A replicate crossover study in healthy Korean male subjects
Abstract |
Fulltext
|
42 |
In-silico design of novel myocilin inhibitors for glaucoma therapy
Abstract |
Fulltext
|
43 |
Molecular docking and in silico ADMET studies of silibinin and glycyrrhetic acid anti-inflammatory activity
Abstract |
Fulltext
|
44 |
Effect of Carica papaya (Linn) aqueous leaf extract on pharmacokinetic profile of ciprofloxacin in rabbits
Abstract |
Fulltext
|
45 |
Characterization and identification of in vitro metabolites of (-)-epicatechin using ultra-high performance liquid chromatography-mass spectrometry
Abstract |
Fulltext
|
46 |
Pharmacological activities and pharmacokinetic study of hyperoside: A short review
Abstract |
Fulltext
|
47 |
Optimization and validation of high performance liquid chromatography-ultra violet method for quantitation of metoprolol in rabbit plasma: application to pharmacokinetic studies
Abstract |
Fulltext
|
48 |
Pharmacokinetics of caffeic acid from methanol seed extract of Syzygium cumini L in rats
Abstract |
Fulltext
|
49 |
Pharmacokinetic interaction between magnolol and piperine in rats
Abstract |
Fulltext
|
50 |
In vivo and in silico investigation of selected herbal compounds as anti-tubercular agents
Abstract |
Fulltext
|
51 |
Bioequivalence evaluation of new microparticulate capsule and marketed tablet dosage forms of lornoxicam in healthy volunteers
Abstract |
Fulltext
|
52 |
Health benefits of theanine in green tea: A review
Abstract |
Fulltext
|
53 |
Development and validation of reverse phase high performance chromatography method for determination of olanzapine in microsample rat plasma: Application to preclinical pharmacokinetic study
Abstract |
Fulltext
|
54 |
A review on chemical constituents and biological activities of the Genus Beilschmiedia (Lauraceae)
Abstract |
Fulltext
|
55 |
Coordination compounds of M(II) biometal Ions with acid-type anti-inflammatory drugs as ligands – A review
Abstract |
Fulltext
|
56 |
Formulation and pharmacokinetic evaluation of controlled-release oxybutynin tablets in dogs
Abstract |
Fulltext
|
57 |
New highly-sensitive ultra-performance liquid chromatography - mass spectrometry method for quantification of telmisartan in human plasma
Abstract |
Fulltext
|
58 |
Evaluation of information contained in drug advertisement and promotion materials in Nigeria
Abstract |
Fulltext
|
59 |
Avanafil liposomes as transdermal drug delivery for erectile dysfunction treatment: Preparation, characterization, and in vitro, ex vivo and in vivo studies
Abstract |
Fulltext
|
60 |
Effect of smoking on pharmacokinetics of clopidogrel, an antiplatelet drug
Abstract |
Fulltext
|
61 |
Simultaneous determination of flavonols and terpene lactones in beagle dog plasma by ultra-performance liquid chromatography tandem mass spectrometry: 2. Application to pharmacokinetic studies on ginkgo leaf extract
Abstract |
Fulltext
|
62 |
Plasma pharmacokinetic and heart distribution studies of Z-GP-EPI, a hypocardiotoxic prodrug of epirubicin
Abstract |
Fulltext
|
63 |
Enhancement of aqueous solubility and oral bioavailability of nelfinavir by complexation with ß-cyclodextrin
Abstract |
Fulltext
|
64 |
Synergism in pharmacokinetics of retagliptin and metformin observed during clinical trials of their combination therapy
Abstract |
Fulltext
|
65 |
Evaluation of In vitro and In vivo Performance of Granisetron In situ Forming Implants: Effect of Sterilization, Storage Condition and Degradation
Abstract |
Fulltext
|
66 |
Preliminary Investigation of Beagle Dog as Substitute for Humans in Bioequivalence Studies
Abstract |
Fulltext
|
67 |
A Simple HPLC Bioanalytical Method for the Determination of Doxorubicin Hydrochloride in Rat Plasma: Application to Pharmacokinetic Studies
Abstract |
Fulltext
|
68 |
Formulation and Evaluation of Mouth Dissolving Tablets of Tramadol Hydrochloride
Abstract |
Fulltext
|
69 |
Validated High Performance Liquid Chromatography Method for Analysis of Cefadroxil Monohydrate in Human Plasma
Abstract |
Fulltext
|
70 |
Development and In vitro Evaluation of Flurbiprofen Microcapsules Prepared by Modified Solvent Evaporation Technique
Abstract |
Fulltext
|
71 |
Validation of Individual Non-Linear Predictive Pharmacokinetic Parameters in a Rabbit Phenytoin Model
Abstract |
Fulltext
|
72 |
Pharmacokinetic Study of a Capsule-based Chronomodulated Drug Delivery System of Salbutamol Sulphate in Rabbits
Abstract |
Fulltext
|
73 |
Preparation, Characterisation and In Vivo Evaluation of Silybin Nanoparticles for the Treatment of Liver Fibrosis
Abstract |
Fulltext
|
74 |
Adsorptive Cathodic Stripping Voltammetric Determination of Ciprofloxacin in Bulk Powder, Pharmaceutical Dosage Forms and Urine
Abstract |
Fulltext
|
75 |
Biopharmaceutical Classification System in In-vitro/In-vivo Correlation: Concept and Development Strategies in Drug Delivery
Abstract |
Fulltext
|
76 |
Validated HPLC–MS/MS Method for Simultaneous Determination of Curcumin and Piperine in Human Plasma
Abstract |
Fulltext
|
77 |
New Analytical Method for the Determination of Metronidazole in Human Plasma: Application to Bioequivalence Study
Abstract |
Fulltext
|
78 |
Preparation of Mucoadhesive Patches for Buccal Administration of Metoprolol Succinate: In Vitro and In Vivo Drug Release and Bioadhesion
Abstract |
Fulltext
|
79 |
Pharmacokinetic Studies on Metoprolol - Eudragit Matrix Tablets and Bioequivalence Consideration with Mepressor
Abstract |
Fulltext
|
80 |
Glipizide Pharmacokinetics in Healthy and Diabetic Volunteers
Abstract |
Fulltext
|
81 |
Preparation, Characterisation and In vivo Evaluation of Bis-demethoxy Curcumin Analogue (BDMCA) Nanoparticles
Abstract |
Fulltext
|
82 |
A Comparative Study of the Pharmacokinetics of Conventional and Sustained-release Tablet Formulations of Aceclofenac in Healthy Male Subjects
Abstract |
Fulltext
|
83 |
Arformoterol Tartrate: A Review of Pharmacology, Analysis and Clinical Studies
Abstract |
Fulltext
|
84 |
Nanotechnology and Drug Delivery Part 2: Nanostructures for Drug Delivery
Abstract |
Fulltext
|
85 |
In-vivo Kinetics of Silymarin (Milk Thistle) on Healthy Male Volunteers
Abstract |
Fulltext
|
86 |
Pharmacokinetic Study of Nifedipine in Healthy Adult Male Human Volunteers
Abstract |
Fulltext
|
87 |
Chronotherapeutics and Chronotherapeutic Drug Delivery Systems
Abstract |
Fulltext
|
88 |
Simultaneous quantitative determination of zidovudine and nevirapine in human plasma using isocratic, reverse phase high performance liquid chromatography
Abstract |
Fulltext
|
89 |
Preparation of Polymeric Micelles for use as Carriers of Tuberculostatic Drugs.
Abstract |
Fulltext
|
90 |
Nanoparticles - A Review
Abstract |
Fulltext
|
90 matching items found
|
Archives
2025; 24: |
1,
2,
3.
|
2024; 23: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
2023; 22: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
2022; 21: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
2021; 20: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
2020; 19: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
2019; 18: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
2018; 17: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
2017; 16: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
2016; 15: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
2015; 14: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
2014; 13: |
1,
2,
3,
4,
5,
6,
7,
8,
9,
10,
11,
12.
|
2013; 12: |
1,
2,
3,
4,
5,
6.
|
2012; 11: |
1,
2,
3,
4,
5,
6.
|
2011; 10: |
1,
2,
3,
4,
5,
6.
|
2010; 9: |
1,
2,
3,
4,
5,
6.
|
2009; 8: |
1,
2,
3,
4,
5,
6.
|
2008; 7: |
1,
2,
3,
4.
|
2007; 6: |
1,
2,
3,
4.
|
2006; 5: |
1,
2.
|
2005; 4: |
1,
2.
|
2004; 3: |
1.
|
2003; 2: |
1,
2.
|
2002; 1: |
1,
2.
|
|